What Regulators Expect in AI-Powered Validation: Moving from Data Integrity to Decision Integrity

Ryan Chen

Author

Ryan Chen

Product Strategist

ValGenesis

LinkedIn

Published on April 16, 2026
Reading time: -- minutes
Last updated on April 16, 2026
Reviewed by: Lisa Weeks

Summary

AI-assisted validation rises or falls on evidence: whether it can be trusted, explained, and defended during inspection. The focus is less on the model and more on how AI outputs become validated decisions. 

ALCOA+ still applies, but regulators now want “decision integrity”: visible AI contributions, clear human ownership, and records that show what was accepted, changed, or rejected—plus signatures that prove active review.

Key Takeaways

  • ALCOA+ fundamentals stay the same, but attribution and accuracy must separate AI-generated content from human edits and approvals.
     
  • Audit trails need to show the decision pathway (including rejected AI suggestions), not only timestamps and change logs.
     
  • E-signatures must represent informed accountability, with evidence of a real review step before approval.
     
  • Treat AI as a visible participant in the workflow, with AI-generated suggestions clearly distinguished from human-authored refinements and tied to a responsible human owner.
     
  • Capture the “messy middle” in the record (what was accepted, modified, or rejected and when), so inspection evidence shows the decision path instead of relying on after-the-fact reconstruction.

Who is this for

  • Computer system validation (CSV) / computer software assurance (CSA) leads
  • Quality assurance (QA) and quality systems managers
  • GxP IT and platform owners (eQMS, validation tooling, LIMS/ELN)
  •  Data integrity and audit trail reviewers/compliance leads
  • Validation engineers and process owners introducing AI into workflows
  • Regulatory affairs and inspection readiness teams
  • Subject matter experts (SMEs) who review/approve validation deliverables 
featured image

Across life sciences, there is a growing assumption that regulatory scrutiny of artificial intelligence (AI) will focus primarily on technical models and algorithms. In practice, that is not where inspections begin. They begin with evidence. 

When AI is involved in validation—whether generating protocols, assessing gaps, or identifying anomalies—the core question is simple: Can this evidence be trusted, explained, and defended under inspection? For many organizations, this is where the breakdown occurs. This is due to insufficient science. It’s because the structure of the validation evidence hasn’t evolved to reflect how AI contributes to decisions.

 

The Evolution of ALCOA+: Why Data Integrity Is No Longer Enough

ALCOA+ has long defined the standard for data integrity, ensuring records are attributable, legible, contemporaneous, original, and accurate. While that foundation remains unchanged in an AI-driven environment, the nature of the evidence itself is shifting. 

Validation evidence is no longer just recorded by a human; it is now partially generated, interpreted, and influenced by AI systems. Consequently, regulators are moving beyond evaluating whether data is intact to assessing decision integrity. They need to see a transparent audit trail of how a conclusion was reached, how the AI’s output was verified, and how the final decision remained firmly under human authority throughout the lifecycle.

 

The "Invisible Author" Risk: Why Attribution Is Breaking Down

In traditional validation, attribution is linear: a person writes, a person reviews, and a person approves. In AI-assisted workflows, attribution becomes layered and often blurred. If a protocol originates from an AI draft and is refined by multiple subject matter experts (SMEs), the human-in-the-loop can easily become obscured within the system. 

From a regulatory standpoint, if a system does not clearly distinguish between AI-generated suggestions and human-authored refinements, accountability is lost.

Regulators increasingly expect AI to be treated as a visible participant in the process—rather than an invisible author embedded within it—ensuring that every automated contribution is mapped to a human owner who takes responsibility for its accuracy.

 

Audit Trails Must Explain Why, Not Just When

Standard audit trails are designed to record actions, providing a chronological log of changes. However, in an AI environment, inspectors are looking for the decision pathway. They want to understand the evolution of the record: what the AI suggested, which parts were modified, and—most importantly—what was rejected by the human reviewer. 

Many legacy systems capture timestamps but fail to capture this critical context. Under inspection, this forces teams to reconstruct their control strategy from memory rather than demonstrate it through real-time data. Without this underlying logic, an audit trail becomes a sequence of actions without regulatory meaning, making it nearly impossible to defend the integrity of the final output.

 

E-Signatures and the Trap of Passive Acceptance

An e-signature represents informed accountability and a commitment that the signer has reviewed the content. If AI generates validation content and users sign off without full visibility into the underlying logic, the signature risks becoming a procedural rubber stamp rather than a meaningful endorsement.

Regulators are now evaluating whether the intent behind the signature still holds in an automated world. They are looking for evidence of meaningful human oversight, which requires proving that the user actively evaluated the AI's output through a dedicated review step rather than passively accepting a machine-generated draft as truth.

 

Designing Evidence for the AI Era

AI is not fundamentally changing what regulators expect; it is exposing whether organizations were ever truly meeting those expectations to begin with. To scale AI with confidence, organizations must move beyond treating validation evidence as static documentation. It must function as a defensible, traceable narrative.

By making AI contributions visible, capturing decision points instead of just final outcomes, and ensuring audit trails reflect scientific reasoning, companies can turn compliance from a hurdle into a significant competitive advantage.

 

 

 

 

Table of Contents

    Citations

    1

    Office of the Federal Register, National Archives and Records Administration. (n.d.). 21 CFR Part 11—Electronic records; electronic signatures. Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-11?utm_

    Electronic Code of Federal Regulations. Accessed Date: 14 April 2026.

    2

    U.S. Food and Drug Administration. (2003) https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application?utm_

    Part 11, electronic records; electronic signatures—Scope and application: Guidance for industry. Accessed Date: 14 April 2026.

    3

    European Commission. (2011). https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf

    EudraLex—The rules governing medicinal products in the European Union, Volume 4: Good manufacturing practice—Annex 11: Computerised systems (Revision 1; effective June 30, 2011). Accessed Date: 14 April 2026.

    4

    Medicines and Healthcare products Regulatory Agency. (2018, March). https://assets.publishing.service.gov.uk/media/5aa2b9ede5274a3e391e37f3/MHRA_GxP_data_integrity_guide_March_edited_Final.pdf

    ‘GXP’ data integrity guidance and definitions (Revision 1). Accessed Date: 14 April 2026.

    The opinions, information and conclusions contained within this blog should not be construed as conclusive fact, ValGenesis offering advice, nor as an indication of future results.

    Related Blog Posts